These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27199539)

  • 1. A multi-parametric protocol to study exercise intolerance in McArdle's disease.
    Ricci G; Bertolucci F; Logerfo A; Simoncini C; Papi R; Franzoni F; Dell'Osso G; Servadio A; Masoni MC; Siciliano G
    Acta Myol; 2015 Dec; 34(2-3):120-125. PubMed ID: 27199539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease.
    Sahlin K; Jorfeldt L; Henriksson KG; Lewis SF; Haller RG
    Clin Sci (Lond); 1995 Jun; 88(6):687-93. PubMed ID: 7634753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No spontaneous second wind in muscle phosphofructokinase deficiency.
    Haller RG; Vissing J
    Neurology; 2004 Jan; 62(1):82-6. PubMed ID: 14718702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease.
    Sahlin K; Areskog NH; Haller RG; Henriksson KG; Jorfeldt L; Lewis SF
    J Appl Physiol (1985); 1990 Oct; 69(4):1231-5. PubMed ID: 2262440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies.
    Chaussain M; Camus F; Defoligny C; Eymard B; Fardeau M
    Eur J Med; 1992 Dec; 1(8):457-63. PubMed ID: 1341204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second wind phenomenon in McArdle's disease.
    Braakhekke JP; de Bruin MI; Stegeman DF; Wevers RA; Binkhorst RA; Joosten EM
    Brain; 1986 Dec; 109 ( Pt 6)():1087-101. PubMed ID: 3466659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unforeseen cardiac involvement in McArdle's disease.
    Moustafa S; Patton DJ; Connelly MS
    Heart Lung Circ; 2013 Sep; 22(9):769-71. PubMed ID: 23337261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of the exercise-induced increase in muscle perfusion in McArdle's disease.
    Jehenson P; Leroy-Willig A; de Kerviler E; Merlet P; Duboc D; Syrota A
    Eur J Nucl Med; 1995 Nov; 22(11):1256-60. PubMed ID: 8575473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
    Lewis SF; Haller RG
    J Appl Physiol (1985); 1986 Aug; 61(2):391-401. PubMed ID: 3528113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. McArdle's disease presenting with asymmetric, late-onset arm weakness.
    Wolfe GI; Baker NS; Haller RG; Burns DK; Barohn RJ
    Muscle Nerve; 2000 Apr; 23(4):641-5. PubMed ID: 10716777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mcardle's disease. A case report.
    Dirik E; Taşkin F; Eroğlu Y; Büyükgebiz B; Selamzade M; Cevik NT
    Turk J Pediatr; 1996; 38(3):355-9. PubMed ID: 8827906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. McArdle's disease presenting as unexplained dyspnea in a young woman.
    Voduc N; Webb KA; D'Arsigny C; McBride I; O'Donnell DE
    Can Respir J; 2004 Mar; 11(2):163-7. PubMed ID: 15045049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [McArdle's disease: a case report].
    Levy JA; Gagioti SM; Cavalieri MJ; Pereira JR
    Arq Neuropsiquiatr; 1980 Dec; 38(4):411-4. PubMed ID: 6937160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise tolerance and daily life in McArdle's disease.
    Ollivier K; Hogrel JY; Gomez-Merino D; Romero NB; Laforêt P; Eymard B; Portero P
    Muscle Nerve; 2005 May; 31(5):637-41. PubMed ID: 15614801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic power of the non-ischaemic forearm exercise test in detecting glycogenosis type V.
    Hogrel JY; van den Bogaart F; Ledoux I; Ollivier G; Petit F; Koujah N; Béhin A; Stojkovic T; Eymard B; Voermans N; Laforêt P
    Eur J Neurol; 2015 Jun; 22(6):933-40. PubMed ID: 25740218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased PFK activity and GLUT4 protein content in McArdle's disease.
    Robertshaw HA; Raha S; Kaczor JJ; Tarnopolsky MA
    Muscle Nerve; 2008 Apr; 37(4):431-7. PubMed ID: 18067156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diagnostic cycle test for McArdle's disease.
    Vissing J; Haller RG
    Ann Neurol; 2003 Oct; 54(4):539-42. PubMed ID: 14520671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen storage disease type V (Mc Ardle's disease): a report on three cases.
    Krishnamoorthy N; Santosh V; Yasha TC; Mahadevan A; Shankar SK; Jethwani D; Taly AB; Bhanu K; Gayathri N
    Neurol India; 2011; 59(6):884-6. PubMed ID: 22234204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal ventilation during exercise in McArdle's syndrome: modulation by substrate availability.
    Haller RG; Lewis SF
    Neurology; 1986 May; 36(5):716-9. PubMed ID: 3458030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.